BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 4387986)

  • 21. Cardiovascular pharmacology of two new beta-adrenergic receptor antagonists.
    Stanton HC; Kirchgessner T; Parmenter K
    J Pharmacol Exp Ther; 1965 Aug; 149(2):174-82. PubMed ID: 4378559
    [No Abstract]   [Full Text] [Related]  

  • 22. Neuroendocrine and metabolic effects of general anaesthesia and graded haemorrhage.
    Dobkin AB; Byles PH; Neville JF
    Can Anaesth Soc J; 1966 Sep; 13(5):453-75. PubMed ID: 4381970
    [No Abstract]   [Full Text] [Related]  

  • 23. [Action of sodium cyanide on cardiac metabolism and systemic, pulmonary and coronary hemodynamics].
    Laubie M; Schmitt H; Peltier J; Drouillat M
    Arch Int Pharmacodyn Ther; 1966 Jan; 159(1):206-18. PubMed ID: 5918762
    [No Abstract]   [Full Text] [Related]  

  • 24. [Influence of some volatile anesthetics (diethyl ether, halothane, methoxyflurane) on the metabolic effects induced with catecholamines].
    Tajoli E; Barusco G; Scalella P; Manani G; Fanchiotti GL
    Acta Anaesthesiol; 1968; ():Suppl 8:357+. PubMed ID: 5757519
    [No Abstract]   [Full Text] [Related]  

  • 25. [The influence of the new inhalation anaesthetic ethrane on myocardial contractility and haemodynamics in comparison to halothane].
    Beer D; Beer R; von Wolff A; Duffner H
    Anaesthesist; 1973 May; 22(5):192-7. PubMed ID: 4578749
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hemodynamic modifications induced by volatile anesthetics halothane, penthrane, ethrane) I. Cardiovascular effects].
    Cacchio M; Data PG; Della Valle R; Di Tano G
    Boll Soc Ital Biol Sper; 1981 Mar; 57(5):540-5. PubMed ID: 7259884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coronary and systemic hemodynamic effects of diazepam (Valium) in the unanesthetized dog.
    Bloor CM; Leon AS; Walker DE
    Res Commun Chem Pathol Pharmacol; 1973 Nov; 6(3):1043-51. PubMed ID: 4760879
    [No Abstract]   [Full Text] [Related]  

  • 28. The cardiovascular effects of octapressin.
    Maxwell GM
    Arch Int Pharmacodyn Ther; 1965 Nov; 158(1):17-23. PubMed ID: 5854045
    [No Abstract]   [Full Text] [Related]  

  • 29. Coronary circulation systemic resistance and capacitance blood vessels of dogs as affected by BAY a 1040.
    Hirakawa S; Ito H; Kondo Y; Watanabe I; Hiei K
    Arzneimittelforschung; 1972 Feb; 22(2):344-9. PubMed ID: 4623698
    [No Abstract]   [Full Text] [Related]  

  • 30. [Action of ethrane on the force-velocity relationship of left ventricular contraction].
    Albano V; Antona A; Bellanca L; Latteri A; Palazzoadriano M
    Boll Soc Ital Biol Sper; 1974 Aug; 50(13):991-5. PubMed ID: 4463991
    [No Abstract]   [Full Text] [Related]  

  • 31. [Serum leucine amino peptidase and fluoride anesthetics. (Experimental research)].
    Bertieri AL; Bertieri A; Antola RM
    Pathologica; 1968; 60(881):43-6. PubMed ID: 4390517
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of halothane-oxygen and Innovar-nitrous oxide-oxygen on the maximum acceleration of left ventricular ejection and the tension-time index in dogs.
    Moran JE; Rusy BF; Vongvisces P; Lattanand S
    Anesth Analg; 1972; 51(3):350-4. PubMed ID: 5064011
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effects of Thalamonal on the coronary circulation and cardiac efficiency].
    Yusa T; Iwatsuki K
    Masui; 1971 May; 20(5):377-81. PubMed ID: 5103809
    [No Abstract]   [Full Text] [Related]  

  • 34. [Action of glucagon on cardiac hemodynamics, coronary circulation and myocardial metabolism in humans].
    Warembourg H; Houdas Y; Bertrand ME; Ketelers JY; Vermeersch M
    Arch Mal Coeur Vaiss; 1969 Aug; 62(8):1080-95. PubMed ID: 4983769
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of various anesthetics on hemodynamics].
    Yoshida Y
    Masui; 1969 Aug; 18(8):685-700. PubMed ID: 4900525
    [No Abstract]   [Full Text] [Related]  

  • 36. Anesthetic potency determined by depression of synaptic transmission.
    De Jong RH; Freund FG; Robles R; Morikawa KI
    Anesthesiology; 1968; 29(6):1139-44. PubMed ID: 4387251
    [No Abstract]   [Full Text] [Related]  

  • 37. Equipotent alveolar concentrations of methoxyflurane, halothane, diethyl ether, fluroxene, cyclopropane, xenon and nitrous oxide in the dog.
    Eger EI; Brandstater B; Saidman LJ; Regan MJ; Severinghaus JW; Munson ES
    Anesthesiology; 1965; 26(6):771-7. PubMed ID: 4378907
    [No Abstract]   [Full Text] [Related]  

  • 38. [Coronary resistance under ether and halothane anesthesia in the dog].
    Wolff G; Niederer W; Grädel E
    Cardiologia (Basel); 1967; 50(4):239-42. PubMed ID: 5589125
    [No Abstract]   [Full Text] [Related]  

  • 39. Monitoring depth of anesthesia.
    Artusio JF; Corssen G; Dornette WH; Reves JG
    Clin Anesth; 1973; 9(2):211-22. PubMed ID: 4150315
    [No Abstract]   [Full Text] [Related]  

  • 40. The systemic and coronary hemodynamic effects of iproveratril.
    Rowe GG; Stenlund RR; Thomsen JH; Corliss RJ; Sialer S
    Arch Int Pharmacodyn Ther; 1971 Oct; 193(2):381-90. PubMed ID: 5000871
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.